Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-02-02Clinical Trial Update: Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts [NA]
A clinical trial of paclitaxel-coated balloon catheters for treating dysfunctional arteriovenous fistulas and grafts has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-01-20Clinical Trial Update: CSPPT- Chronic Kidney Diseases Study [Phase 4]
Phase 4 CSPPT Chronic Kidney Diseases Study has been withdrawn by the sponsor; the trial evaluated treatment in hypertensive patients with h…
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
A pilot trial evaluating cardiovascular events in high-risk orthopedic surgical patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-02Clinical Trial Update: Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis
A clinical trial evaluating the long-term effects of pediatric acute kidney injury in severe sepsis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease [NA]
The Massachusetts General Hospital-sponsored trial evaluating hCAP18 levels and vitamin D deficiency in chronic kidney disease has been with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-09-07Clinical Trial Update: Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 [Phase 1]
A Phase 1 trial investigating the effect of galactose on a permeability factor in patients with Focal Segmental Glomerulosclerosis and Chron…
-
CLINICAL_TRIALS withdrawal · 2015-08-24Clinical Trial Update: The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure [Phase 2]
A Phase 2 trial studying liraglutide in patients with chronic kidney disease and prediabetes has been withdrawn.
-
EMA withdrawal · 2015-07-13EMA Withdrawn: Rienso (Ferumoxytol) — Takeda Pharma A/S
EMA has withdrawn Rienso (ferumoxytol) from the market in Europe.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) [Phase 3]
The SWEEP Phase 3 trial evaluating HX575 for anemia associated with chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant [NA]
The clinical trial NCT01619449 evaluating continuous renal replacement therapy in the setting of orthotopic liver transplantation has been w…
-
CLINICAL_TRIALS withdrawal · 2015-05-21Clinical Trial Update: Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients [Phase 3]
A Phase 3 trial examining diuretic therapy to manage fluid status and preserve residual renal function in peritoneal dialysis patients was w…
-
CLINICAL_TRIALS withdrawal · 2015-05-01Clinical Trial Update: Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function [NA]
A Texas A&M University-sponsored clinical trial examining chronic kidney disease and alterations in protein and amino acid metabolism has be…
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life [Phase 2]
A Phase 2 trial of a Specific Enteral Nutrition product for malnourished patients with chronic kidney disease on hemodialysis has been withd…
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Sympathetic Nerve Activity in Renal Failure [Phase 4]
A Phase 4 clinical trial examining sympathetic nerve activity in chronic kidney disease with hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-09Clinical Trial Update: Optimal Treatment for Kidney Disease in HIV Infected Adults [Phase 3]
A Phase 3 clinical trial evaluating the optimal treatment for kidney disease in HIV-infected adults has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-01-15Clinical Trial Update: A Phase 2 Extension of Study GCS-100-CS-4003 [Phase 2]
A Phase 2 extension study (GCS-100-CS-4003) for chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-25Clinical Trial Update: Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)
The UPSAC trial, investigating ultrasound to predict steal syndrome after arteriovenous fistula creation in chronic kidney disease patients,…
-
CLINICAL_TRIALS withdrawal · 2014-07-29Clinical Trial Update: Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction [NA]
A pharmacokinetic study of fondaparinux in outpatients with renal dysfunction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-21Clinical Trial Update: Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease [NA]
A clinical trial evaluating the effects of Vitamin D on renal blood flow, proteinuria, and inflammation in chronic kidney disease was withdr…
-
CLINICAL_TRIALS withdrawal · 2014-01-27Clinical Trial Update: Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis [Phase 3]
A Phase 3 clinical trial of fasiglifam in type 2 diabetes patients with chronic kidney disease on hemodialysis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-10Clinical Trial Update: The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23. [NA]
A clinical trial evaluating the effects of dietary phosphate intake on calciotropic hormones and FGF23 was withdrawn; the study included hea…
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: A Multi-Center, Open-Label Study [Phase 1]
This document reports a Phase 1, multi-center open-label study sponsored by Chelsea Therapeutics that has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-08Clinical Trial Update: Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease
A clinical trial comparing a non-invasive central venous pressure device to physical examination in patients with chronic kidney disease has…
-
CLINICAL_TRIALS withdrawal · 2012-09-26Clinical Trial Update: Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) [NA]
Clinical trial evaluating the effect of sevelamer on glucose tolerance and insulin sensitivity in chronic kidney disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-06Clinical Trial Update: Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients [Phase 4]
A Phase 4 trial evaluating eplerenone for elderly patients with hypertension and early-stage chronic kidney disease has been withdrawn.